MIR8088

Across TCGA pan-cancer cohorts, MIR8088 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated MIR8088 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR8088 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR8088 expression acts as an unfavorable survival marker.

KIRC, LUSC, and OV are the cancer types where MIR8088 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.127	0.806	<.001	108	view →
LUSC	DFS	Tertile	III,IV	0.010	0.754	<.001	108	view →
OV	DFS	Tertile	II,III,IV	0.220	0.542	.024	54	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	45	view →
STAD	OS	Tertile	All	0.171	0.568	.015	36	view →
LGG	OS	Tertile	All	0.148	0.909	<.001	21	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

MIR8088–KIRC (OS)

Open the KIRC breakdown →